Clinical Trial Update: A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia [Phase 2]

View source ↗

Summary

This update summarizes results from a Phase 2 study of tapentadol extended-release (JNS024ER) in Japanese participants with chronic pain due to diabetic neuropa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Postherpetic Neuralgia

Drugs mentioned

• Tapentadol Extended Release (JNS024ER) (tapentadol)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Pain, Diabetic Neuropathies | Phase 2 | Status: COMPLETED | Results posted: 2013-06-26